Fabric Genomics Announces Early Access to ‘Build 38’ for Improved Clinical Genome Analysis

Latest genome reference build offers enhanced interpretation results; improves clinical workflows and patient care, access to diverse population data October 11, 2018 01:26 PM Pacific Daylight Time OAKLAND, Calif.–(BUSINESS WIRE)–Fabric Genomics™, a global leader in clinical interpretation of genomic data, announced today that it is offering select customers the option of using ‘Build 38,’ the... Read more

Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing

MinIT is out – an analysis and device control accessory to enable powerful, real-time DNA/RNA sequencing by anyone, anywhere Wed 10th October 2018 MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, is now arriving with genomics researchers. Scientists will use it to run the MinION DNA/RNA sequencer, opening up high-throughput, real-time... Read more

Pacific Biosciences Announces a New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads

Significant Enhancements to Sequel System Enable >99% Accuracy for Single-Molecule Reads up to 15 kb; Throughput Increases by 2- to 4-FoldMENLO PARK, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced major enhancements to its Sequel® System, including... Read more

Pacific Biosciences Announces a New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads

Significant Enhancements to Sequel System Enable >99% Accuracy for Single-Molecule Reads up to 15 kb; Throughput Increases by 2- to 4-FoldMENLO PARK, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced major enhancements to its Sequel® System, including... Read more

Pacific Biosciences Releases Highest-Quality, Most Contiguous Individual Human Genome Assembly to Date

MENLO PARK, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced it has produced the most contiguous diploid human genome assembly of a single individual to date, representing the nearly complete DNA sequence from all 46 chromosomes inherited... Read more

PerkinElmer To Hold Earnings Call on Wednesday, October 31, 2018

WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 5, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Wednesday, October 31, 2018, after market close, the Company will release third quarter 2018 results. The Company will also host a conference call the same day at 5:00 p.m. EDT to discuss... Read more

Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD

PDF Version Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a non-exclusive distribution agreement with DNA Software, Inc. to provide CopyCount-CNV™ software for use with the Fluidigm Biomark™ HD system. Copy number variation... Read more

NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program

PDF Version DSP to be Applied to Transplant Research of Regulatory T Cell Therapy in Kidney Transplantation SEATTLE, Oct. 04, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the University of Oxfordhas been selected as the winning recipient of a grant for a GeoMx™... Read more